FOXP3 promotes tumor growth and metastasis by activating Wnt/β-catenin signaling pathway and EMT in non-small cell lung cancer.
Yang S, Liu Y, Li MY, Ng CSH, Yang SL, Wang S, Zou C, Dong Y, Du J, Long X, Liu LZ, Wan IYP, Mok T, Underwood MJ, Chen GG. · 2017
Read FOXP3 promotes tumor growth and metastasis by activating Wnt/β-catenin signaling pathway and EMT in non-small cell lung cancer. by Yang S, Liu Y, Li MY, Ng CSH, Yang SL, Wang S, Zou C, Dong Y, Du J, Long X, Liu LZ, Wan IYP, Mok T, Underwood MJ, Chen GG. (2017) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/europmc-pmc5514503.txt.
Description
Yang and co-authors report a cancer study in Molecular Cancer on the FOXP3 protein in lung cancer. FOXP3 is best known for steering immune cells. Its role inside tumor cells has drawn conflicting claims. The team studied tumor samples from 106 lung surgery patients. Cell lines and mouse grafts backed the clinical data.
Patients with high FOXP3 levels fared worse after surgery, they report. Extra FOXP3 made cancer cells grow, move, and invade faster. It switched on the Wnt growth pathway by teaming with beta-catenin. That switch also drove EMT, the loosening program behind spread. Blocking FOXP3 blunted all these effects.
Catalog record
| CREATOR | Yang S, Liu Y, Li MY, Ng CSH, Yang SL, Wang S, Zou C, Dong Y, Du J, Long X, Liu LZ, Wan IYP, Mok T, Underwood MJ, Chen GG. |
|---|---|
| YEAR | 2017 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 48 KB |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |